{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:33:38Z","timestamp":1780418018944,"version":"3.54.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s12072-025-10924-1","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:20:29Z","timestamp":1761294029000},"page":"81-90","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Comparison of diagnostic criteria for fatty liver disease in assessing cardiac dysfunction: a cross-sectional study"],"prefix":"10.1007","volume":"20","author":[{"given":"Yun Kyung","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo-Jung","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Je","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7606-3521","authenticated-orcid":false,"given":"Hong-Kyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4043-2396","authenticated-orcid":false,"given":"Chang Hee","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"10924_CR1","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1111\/liv.15931","volume":"44","author":"Z Pan","year":"2024","unstructured":"Pan Z, Shiha G, Esmat G, Mendez-Sanchez N, Eslam M. MAFLD predicts cardiovascular disease risk better than MASLD. Liver Int. 2024;44:1567\u20131574","journal-title":"Liver Int"},{"key":"10924_CR2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020;73:202\u2013209","journal-title":"J Hepatol"},{"key":"10924_CR3","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/S2468-1253(21)00183-7","volume":"6","author":"M Eslam","year":"2021","unstructured":"Eslam M, Alkhouri N, Vajro P, Baumann U, Weiss R, Socha P, et al. Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement. Lancet Gastroenterol Hepatol. 2021;6:864\u2013873","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10924_CR4","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78:1966\u20131986","journal-title":"Hepatology"},{"key":"10924_CR5","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.4093\/dmj.2024.0541","volume":"48","author":"J Bae","year":"2024","unstructured":"Bae J, Han E, Lee HW, Park CY, Chung CH, Lee DH, et al. Metabolic dysfunction-associated steatotic liver disease in type 2 diabetes mellitus: a review and position statement of the fatty liver research group of the Korean Diabetes Association. Diabetes Metab J. 2024;48:1015\u20131028","journal-title":"Diabetes Metab J"},{"key":"10924_CR6","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-3979461\/v1","author":"MK Kang","year":"2024","unstructured":"Kang MK, Song J, Loomba R, Park S, Tak W, Kweon Y, et al. Comparative associations of MASLD and MAFLD with the presence and severity of coronary artery calcification. Res Sq. 2024. https:\/\/doi.org\/10.21203\/rs.3.rs-3979461\/v1","journal-title":"Res Sq"},{"key":"10924_CR7","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41569-024-01046-6","volume":"21","author":"MS Khan","year":"2024","unstructured":"Khan MS, Shahid I, Bennis A, Rakisheva A, Metra M, Butler J. Global epidemiology of heart failure. Nat Rev Cardiol. 2024;21:717\u2013734","journal-title":"Nat Rev Cardiol"},{"key":"10924_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327672","author":"A Mantovani","year":"2022","unstructured":"Mantovani A, Petracca G, Csermely A, Beatrice G, Bonapace S, Rossi A, et al. Non-alcoholic fatty liver disease and risk of new-onset heart failure: an updated meta-analysis of about 11 million individuals. Gut. 2022. https:\/\/doi.org\/10.1136\/gutjnl-2022-327672","journal-title":"Gut"},{"key":"10924_CR9","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMra011775","volume":"346","author":"P Angulo","year":"2002","unstructured":"Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221\u20131231","journal-title":"N Engl J Med"},{"key":"10924_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16:233\u2013270","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10924_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.echo.2008.11.023","volume":"22","author":"SF Nagueh","year":"2009","unstructured":"Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr. 2009;22:107\u2013133","journal-title":"J Am Soc Echocardiogr"},{"issue":"216\u2013232","key":"10924_CR12","volume":"32","author":"JJ Silbiger","year":"2019","unstructured":"Silbiger JJ. Pathophysiology and echocardiographic diagnosis of left ventricular diastolic dysfunction. J Am Soc Echocardiogr. 2019;32(216\u2013232): e212","journal-title":"J Am Soc Echocardiogr"},{"key":"10924_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12876-023-02708-4","volume":"23","author":"F Cong","year":"2023","unstructured":"Cong F, Zhu L, Deng L, Xue Q, Wang J. Correlation between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction in non-obese adults: a cross-sectional study. BMC Gastroenterol. 2023;23:90","journal-title":"BMC Gastroenterol"},{"key":"10924_CR14","doi-asserted-by":"publisher","first-page":"22917","DOI":"10.1038\/s41598-024-74287-7","volume":"14","author":"MK Kang","year":"2024","unstructured":"Kang MK, Song JE, Loomba R, Park SY, Tak WY, Kweon YO, et al. Comparative associations of MASLD and MAFLD with the presence and severity of coronary artery calcification. Sci Rep. 2024;14:22917","journal-title":"Sci Rep"},{"key":"10924_CR15","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.3390\/jcm14082690","volume":"14","author":"A Sonaglioni","year":"2025","unstructured":"Sonaglioni A, Cerini F, Fagiani V, Nicolosi GL, Rumi MG, Lombardo M, et al. Effect of metabolic dysfunction-associated steatotic liver disease (MASLD) on left ventricular mechanics in patients without overt cardiac disease: a systematic review and meta-analysis. J Clin Med. 2025;14:2690","journal-title":"J Clin Med"},{"key":"10924_CR16","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s12072-023-10620-y","volume":"18","author":"MM Ramirez-Mejia","year":"2024","unstructured":"Ramirez-Mejia MM, Jimenez-Gutierrez C, Eslam M, George J, Mendez-Sanchez N. Breaking new ground: MASLD vs. MAFLD-which holds the key for risk stratification? Hepatol Int. 2024;18:168\u2013178","journal-title":"Hepatol Int"},{"key":"10924_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2025.104024","volume":"35","author":"H Jin","year":"2025","unstructured":"Jin H, Liang Z, Hu X, Li X, Liu Z, Qiao Y, et al. Comparative association of MAFLD\/MASLD and subtypes with cardiovascular diseases outcomes. Nutr Metab Cardiovasc Dis. 2025;35: 104024","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10924_CR18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jacc.2013.10.055","volume":"63","author":"BD Hoit","year":"2014","unstructured":"Hoit BD. Left atrial size and function: role in prognosis. J Am Coll Cardiol. 2014;63:493\u2013505","journal-title":"J Am Coll Cardiol"},{"key":"10924_CR19","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.jcmg.2012.06.003","volume":"5","author":"AC Armstrong","year":"2012","unstructured":"Armstrong AC, Gidding S, Gjesdal O, Wu C, Bluemke DA, Lima JA. LV mass assessed by echocardiography and CMR, cardiovascular outcomes, and medical practice. JACC Cardiovasc Imaging. 2012;5:837\u2013848","journal-title":"JACC Cardiovasc Imaging"},{"key":"10924_CR20","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s00125-010-1682-3","volume":"53","author":"H von Bibra","year":"2010","unstructured":"von Bibra H, St John Sutton M. Diastolic dysfunction in diabetes and the metabolic syndrome: promising potential for diagnosis and prognosis. Diabetologia. 2010;53:1033\u20131045","journal-title":"Diabetologia"},{"issue":"1157\u20131164","key":"10924_CR21","volume":"17","author":"ZP Fricker","year":"2019","unstructured":"Fricker ZP, Pedley A, Massaro JM, Vasan RS, Hoffmann U, Benjamin EJ, et al. Liver fat is associated with markers of inflammation and oxidative stress in analysis of data from the framingham heart study. Clin Gastroenterol Hepatol. 2019;17(1157\u20131164): e1154","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10924_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13453","volume":"20","author":"T Mesquita","year":"2021","unstructured":"Mesquita T, Lin YN, Ibrahim A. Chronic low-grade inflammation in heart failure with preserved ejection fraction. Aging Cell. 2021;20: e13453","journal-title":"Aging Cell"},{"key":"10924_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4093\/dmj.2019.0185","volume":"44","author":"J Gollmer","year":"2020","unstructured":"Gollmer J, Zirlik A, Bugger H. Mitochondrial mechanisms in diabetic cardiomyopathy. Diabetes Metab J. 2020;44:33\u201353","journal-title":"Diabetes Metab J"},{"key":"10924_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13430","volume":"228","author":"M Makrecka-Kuka","year":"2020","unstructured":"Makrecka-Kuka M, Liepinsh E, Murray AJ, Lemieux H, Dambrova M, Tepp K, et al. Altered mitochondrial metabolism in the insulin-resistant heart. Acta Physiol. 2020;228: e13430","journal-title":"Acta Physiol"},{"key":"10924_CR25","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/hep.30429","volume":"70","author":"RS Khan","year":"2019","unstructured":"Khan RS, Bril F, Cusi K, Newsome PN. Modulation of insulin resistance in nonalcoholic fatty liver disease. Hepatology. 2019;70:711\u2013724","journal-title":"Hepatology"},{"key":"10924_CR26","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1159\/000539371","volume":"17","author":"European Association for the Study of the L, European Association for the Study of D, European Association for the Study of O","year":"2024","unstructured":"European Association for the Study of the L, European Association for the Study of D, European Association for the Study of O. EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Obes Facts. 2024;17:374\u2013444","journal-title":"Obes Facts"},{"key":"10924_CR27","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3350\/cmh.2023.0205","volume":"29","author":"VH Nguyen","year":"2023","unstructured":"Nguyen VH, Le I, Ha A, Le RH, Rouillard NA, Fong A, et al. Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: a longitudinal real-world study. Clin Mol Hepatol. 2023;29:1002\u20131012","journal-title":"Clin Mol Hepatol"},{"key":"10924_CR28","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1001\/jama.2021.15187","volume":"326","author":"J He","year":"2021","unstructured":"He J, Zhu Z, Bundy JD, Dorans KS, Chen J, Hamm LL. Trends in cardiovascular risk factors in US adults by race and ethnicity and socioeconomic status, 1999\u20132018. JAMA. 2021;326:1286\u20131298","journal-title":"JAMA"},{"key":"10924_CR29","doi-asserted-by":"publisher","first-page":"19475","DOI":"10.1038\/s41598-022-21878-x","volume":"12","author":"SM Lopez-Neyman","year":"2022","unstructured":"Lopez-Neyman SM, Davis K, Zohoori N, Broughton KS, Moore CE, Miketinas D. Racial disparities and prevalence of cardiovascular disease risk factors, cardiometabolic risk factors, and cardiovascular health metrics among US adults: NHANES 2011\u20132018. Sci Rep. 2022;12:19475","journal-title":"Sci Rep"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-025-10924-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-025-10924-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-025-10924-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:26:49Z","timestamp":1774434409000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-025-10924-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10924"],"URL":"https:\/\/doi.org\/10.1007\/s12072-025-10924-1","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yun Kyung Cho, Myung Jin Kim, Eun Hee Kim, Min Jung Lee, Hyo-Jung Nam, Woo Je Lee, Hong-Kyu Kim and Chang Hee Jung have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"The study protocol was approved by the Institutional Review Board of Asan Medical Centre (IRB No. 2023-1360). The requirement for written informed consent was waived due to the study's retrospective nature and the use of pre-existing, de-identified clinical data. This study was conducted in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}